CIA
NVS icon

Concurrent Investment Advisors’s Novartis NVS Stock Holding History

Concurrent Investment Advisors’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.24M Buy
20,676
+5,843
+39% +$876K 0.03% 564
2026
Q1 		$2.27M Buy
14,833
+18
+0.1% +$2.76K 0.02% 571
2025
Q4 		$2.04M Buy
14,815
+3,967
+37% +$519K 0.02% 566
2025
Q3 		$1.39M Buy
10,848
+185
+2% +$22.6K 0.02% 558
2025
Q2 		$1.29M Buy
10,663
+4,868
+84% +$549K 0.02% 536
2025
Q1 		$646K Buy
5,795
+1,652
+40% +$176K 0.02% 671
2024
Q4 		$403K Buy
4,143
+409
+11% +$43.6K 0.01% 735
2024
Q3 		$429K Buy
3,734
+393
+12% +$44.6K 0.01% 666
2024
Q2 		$356K Buy
3,341
+317
+10% +$31.8K 0.01% 685
2024
Q1 		$293K Buy
+3,024
New +$310K 0.01% 683

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Concurrent Investment Advisors's NVS Position: Q2 2026 in Review

Concurrent Investment Advisors increased its Novartis (NVS) stake by 39% in Q2 2026, buying an estimated $876K and bringing the position to 20,676 shares worth $3.24M. The position accounts for 0.03% of the portfolio, ranked #564.

Concurrent Investment Advisors first reported a position in NVS in Q1 2024 and has held it in 10 quarters since. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Concurrent Investment Advisors held 20,676 shares of Novartis worth $3.24M as of Q2 2026.
  • Concurrent Investment Advisors bought 5,843 Novartis shares in Q2 2026, an estimated $876K.
  • Novartis made up 0.03% of Concurrent Investment Advisors's portfolio in Q2 2026, its #564 holding.
  • Concurrent Investment Advisors first reported a position in Novartis in Q1 2024 and has held it in 10 quarters since.
  • 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.